Public Company News

New Oriental Announces Results for the Fourth Fiscal Quarter and the Fiscal Year Ended May 31, 2024

BEIJING, July 31, 2024 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational services inChina, today announced its unaudited financial results for the fourth fiscal quarter and fiscal year endedMa...

2024-07-31 17:06 4159

Weibo Corporation to Report Second Quarter 2024 Financial Results on August 22, 2024

BEIJING, July 31, 2024 /PRNewswire/ -- Weibo Corporation (Nasdaq: WB and HKEX: 9898), a leading social media for people to create, share and discover content, will announce its unaudited financial results for the second quarter 2024 before the U.S. market opens onThursday, August 22, 2024. Follow...

2024-07-31 17:00 3964

Uxin Reports Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results

BEIJING, July 31, 2024 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN),China's leading used car retailer, today announced its unaudited financial results for the fourth quarter and fiscal year endedMarch 31, 2024. Dear Shareholders, First and foremost, on behalf of Uxin, I ...

2024-07-31 16:30 5446

LEOTEK Acquires Traffic Business from LED Giant Dialight, Becoming the Top Traffic Signal Solution Provider for Efficient, Low-Carbon AI City Management in the Americas.

SAN JOSE, Calif., July 31, 2024 /PRNewswire/ -- LEOTEK, a San Jose based traffic IoT operation service provider, has acquired the traffic business of Dialight, a renowned Global Leader in LED industrial lighting manufacturer. President Torrent Chin stated,"This acquisition represents LEOTEK's str...

2024-07-31 16:00 2528

Golden Heaven Group Holdings Ltd. Announces Financial Results for the First Half of Fiscal Year 2024

NANPING, China, July 30, 2024 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. ("Golden Heaven" or the "Company") (Nasdaq: GDHG), an amusement park operator in China, today announced its unaudited financial results for the six months ended March 31, 2024 ("First Half 2024"). First Half 2024 Fina...

2024-07-31 04:05 4765

Porton Advanced and Geneseed Biotech Enter into Strategic Collaboration to Focus on Advancing circRNA Innovative Therapeutics

SUZHOU, China, July 30, 2024 /PRNewswire/ -- On July 29, 2024, Porton Advanced Solutions ("Porton Advanced") announced that it had reached a strategic cooperation with Guangzhou Geneseed Biotech Co., Ltd ("Geneseed Biotech"). Both sides will combine their respective strengths in the field of gene...

2024-07-30 22:00 3926

Puyi Fund of Highest Performances Holdings Inc.(NASDAQ: HPH) Wins "2024 Outstanding Wealth Management Award"

GUANGZHOU, China, July 30, 2024 /PRNewswire/ -- The 13th CFS Finance Summit and Amazing 2024 Innovative Entrepreneur Festival concluded successfully inBeijing. Fanhua Puyi Fund Distribution Co., Ltd., ("Puyi Fund" or the "Company"), a subsidiary of Highest Performances Holdings Inc.(NASDAQ: HPH) ...

2024-07-30 21:35 4904

POP MART: Unveiling an Innovative Retail Experience at the Louvre

BEIJING, July 30, 2024 /PRNewswire/ -- POP MART proudly announced the grand opening of its new store in the Louvre, a historic first for this iconic museum , onJuly 27, 2024. Strategically located in the Carrousel du Louvre, near the museum's secondary entrance and the glass pyramid, the store uni...

2024-07-30 21:00 9320

SK hynix Enhances Leadership in Graphics Memory With Introduction of Industry's Best GDDR7

* Industry's best-performing graphics memory with improvement of 60% in speed, 50% in power efficiency to be mass produced in 3Q24 * GDDR7 processes data equivalent to 300 Full-HD movies in a second when combined with high-end graphics card * AI, high-performance computing, autonomous vehicl...

2024-07-30 08:00 2770

Bridge Biotherapeutics Announces Completion of Enrollment in the Phase 2a Clinical Study of BBT-877 for the Treatment of Idiopathic Pulmonary Fibrosis

SEONGNAM, South Korea, July 29, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based inSouth Korea developing novel drugs for fibrosis and cancer, today announced that patient participant enrollment has been completed in the Phase 2 clinical study of BBT-...

2024-07-30 06:00 2605

Nature's Miracle Holding Inc. Announces Closing of $1.2 Million Public Offering

ONTARIO, Calif., July 29, 2024 /PRNewswire/ -- Nature's Miracle Holding Inc.  (NASDAQ: NMHI) ("Nature's Miracle" or the "Company"), today closed its previously announced underwritten public offering of 5,000,000 shares of common stock, par value$0.0001 per share, at a public offering price of $0.2...

2024-07-30 04:05 4298

WiMi Announced a Blockchain-based Framework for Secure Data Sharing in Smart Cities

BEIJING, July 29, 2024 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced a blockchain-based privacy security protection framework will provide an innovative solution for secure...

2024-07-29 21:00 5035

Hesai and Westwell Partner to Accelerate Global Expansion in Autonomous Driving for Logistics

PALO ALTO, Calif., July 29, 2024 /PRNewswire/ -- Hesai Technology (Nasdaq: HSAI), the global leader in lidar solutions, announced that it has entered into a strategic partnership with Westwell, a global provider in autonomous driving solutions, to provide lidar in applications including autonomou...

2024-07-29 20:30 5164

Snail Games Cools Off the Summer Heat Acquiring Publishing Rights To Two Chilling New Horror Games for Indie Branch Wandering Wizard

CULVER CITY, Calif., July 29, 2024 /PRNewswire/ -- Snail, Inc. (Nasdaq: SNAL) ("Snail"), a leading, global independent developer and publisher of interactive digital entertainment, announces that its indie branch,Wandering Wizard , has strategically acquired the ...

2024-07-29 20:00 2621

Vipshop Releases 2023 Environmental, Social and Governance (ESG) Report

Adhering to brands discount retailing, co-creating a new sustainable life GUANGZHOU, China, July 29, 2024 /PRNewswire/ -- Vipshop, a leading online discount retailer for brands inChina ("Vipshop" or the "Company"), recently released its 2023 Environmental, Social, and Governance (ESG) Report (her...

2024-07-29 20:00 3248

Daewoong Pharmaceutical Receives Positive Recommendation from IDMC to Continue Developing its First-in-Class PRS Inhibitor, Bersiporocin

SEOUL, South Korea, July 29, 2024 /PRNewswire/ -- Daewoong Pharmaceutical (Co-CEOsChang-Jae Lee and Seongsoo Park) announced a significant milestone in the development of 'Bersiporocin (DWN12088)', a first-in-class PRS inhibitor for idiopathic pulmonary fibrosis (IPF), has taken a significant ste...

2024-07-29 20:00 3063

Despite External Challenges, WuXi AppTec Maintained Stable Operations in First Half of 2024; Revenue and Profit of the Second Quarter Both Steadily Improved QoQ as Expected, with Revenue Up 16.0% QoQ and Adjusted Non-IFRS Net Profit Up 28.5% QoQ

* Revenue Reached RMB9,259 Million in the Second Quarter, Excluding COVID-19 Commercial Projects, Up 0.3% Year-over-Year * Revenue Reached RMB17,241 Million for the First Half, Excluding COVID-19 Commercial Projects, Down 0.7% Year-over-Year * Net Profit Attributable to the Owners of the Com...

2024-07-29 19:05 5417

CHINA YUCHAI INTERNATIONAL TO ANNOUNCE UNAUDITED 2024 FIRST-HALF YEAR FINANCIAL RESULTS ON AUGUST 12, 2024

- Earnings Call to Begin at 8:00 A.M. EDT – SINGAPORE, July 29, 2024 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company"), announced today that it will be releasing its 2024 unaudited first-half year financial results onMonday, August 12, 2024 before ...

2024-07-29 18:00 2816

Akeso's sBLA for Ivonescimab in 1L Treatment of PD-L1 Positive NSCLC Accepted by NMPA

HONG KONG, July 29, 2024 /PRNewswire/ -- Akeso (9926.HK) is delighted to announce that the supplemental biologics license application (sBLA) for its independently developed, world's first-in-class PD-1/VEGF bispecific antibody drug, 依达方® (generic name: ivonescimab Injection), as a monotherapy for...

2024-07-29 17:26 2921

111 to Announce Second Quarter 2024 Unaudited Financial Results on August 29, 2024 - Conference Call to Follow

SHANGHAI, July 29, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream inChina, today announced that it will repor...

2024-07-29 13:00 2509
1 ... 269270271272273274275 ... 765

Week's Top Stories